NCT03904199View on ClinicalTrials.gov

Prospective Study of Personalized Approach to Inpatient Patients With Hyperglycemia

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

April 4, 2019

Primary Completion Date

October 14, 2020

Study Completion Date

November 2, 2021

Conditions
Hyperglycemia
Interventions
DRUG

Insulin

Participants will receive long-acting insulin and/or rapid-acting insulin per protocol

Trial Locations (1)

33612

Moffitt Cancer Center, Tampa

All Listed Sponsors
lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER

NCT03904199 - Prospective Study of Personalized Approach to Inpatient Patients With Hyperglycemia | Biotech Hunter | Biotech Hunter